StockData
Aprea Therapeutics, Inc. logo

Aprea Therapeutics, Inc. (APRE) stock

APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$0.46+0.01 (+2.60%)

Close on Nov 18, 2026Market cap $5.85MP/E –Yield –

Aprea Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Aprea Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.17M. For fiscal 2025 it was -$12.89M. The highest annual figure on record is -$12.18M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.89M–
FY2024Dec 31, 2024-$13.56M–
FY2023Dec 31, 2023-$12.18M–
FY2022Dec 31, 2022-$25.01M–
FY2021Dec 31, 2021-$37.69M–
FY2020Dec 31, 2020-$41.80M–
FY2019Dec 31, 2019-$26.71M–
FY2018Dec 31, 2018-$15.25M–
FY2017Dec 31, 2017-$14.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.28M–
Q1 FY2026Mar 31, 2026-$2.76M–
Q4 FY2025Dec 31, 2025-$2.96M–
Q3 FY2025Sep 30, 2025-$3.17M–
Q2 FY2025Jun 30, 2025-$3.13M–
Q1 FY2025Mar 31, 2025-$3.63M–
Q4 FY2024Dec 31, 2024-$3.51M–
Q3 FY2024Sep 30, 2024-$2.47M–
Q2 FY2024Jun 30, 2024-$3.64M–
Q1 FY2024Mar 31, 2024-$3.94M–
Q4 FY2023Dec 31, 2023-$3.74M–
Q3 FY2023Sep 30, 2023-$2.24M–
Q2 FY2023Jun 30, 2023-$3.22M–
Q1 FY2023Mar 31, 2023-$2.98M–
Q4 FY2022Dec 31, 2022-$4.02M–
Q3 FY2022Sep 30, 2022-$6.59M–
Q2 FY2022Jun 30, 2022-$8.90M–
Q1 FY2022Mar 31, 2022-$5.50M–
Q4 FY2021Dec 31, 2021-$10.18M–
Q3 FY2021Sep 30, 2021-$8.23M–
Q2 FY2021Jun 30, 2021-$7.75M–
Q1 FY2021Mar 31, 2021-$11.52M–
Q4 FY2020Dec 31, 2020-$13.20M–
Q3 FY2020Sep 30, 2020-$11.42M–
Q2 FY2020Jun 30, 2020-$9.64M–
Q1 FY2020Mar 31, 2020-$7.54M–
Q4 FY2019Dec 31, 2019-$14.74M–
Q3 FY2019Sep 30, 2019-$2.79M–
Q2 FY2019Jun 30, 2019-$4.98M–
Q1 FY2019Mar 31, 2019-$4.20M–
Q4 FY2018Dec 31, 2018-$3.85M–

More Aprea Therapeutics figures

See a number that looks wrong?